gearinjectuk.com
No products in the cart.
Return To Shopgearinjectuk.com
No products in the cart.
Return To ShopFinding the right performance-enhancing substances is crucial for athletes aiming to maximize their potential. Aranesp 30 mcg Amgen is a leading choice for those looking to elevate their endurance and overall athletic performance. Our platform offers this product at a competitive price, ensuring you can access quality performance enhancement without breaking the bank. By choosing us, you gain confidence in acquiring genuine Aranesp, backed by reliable customer service and fast shipping.
Aranesp, produced by Amgen, is a recombinant form of human erythropoietin (EPO), primarily designed to treat anemia due to chronic kidney disease or chemotherapy. Each 30 mcg dose contains a sterile solution that promotes red blood cell production in the bone marrow. This increase in red blood cells enhances oxygen transportation throughout the body, particularly beneficial for athletes engaged in endurance sports. The key ingredient, darbepoetin alfa, has a longer half-life, allowing less frequent administration compared to traditional EPO. It presents itself as a clear, colorless solution for injection, making it user-friendly for those familiar with self-administration.
Aranesp functions by mimicking the action of natural erythropoietin produced by the kidneys, which regulates red blood cell production. By binding to the erythropoietin receptor on erythroid progenitor cells in the bone marrow, it stimulates their proliferation and differentiation into mature red blood cells. This process not only elevates hemoglobin levels but also enhances hematocrit, leading to increased blood viscosity. As a result, the oxygen-carrying capacity of the blood improves, allowing for better muscular endurance and overall performance during physical activities.
Athletes using Aranesp often report noticeable improvements in their performance metrics. Research indicates that those using EPO, including Aranesp, display enhanced aerobic capacity, allowing them to sustain prolonged physical exertion with reduced perceived exertion. Studies suggest that red cell mass can significantly influence endurance performance, resulting in time savings in long-distance events. These enhancements can be critical in competitive environments, where even minor improvements can distinguish champions from contenders. Athletes involved in sports such as cycling, running, and cross-country skiing have shared testimonials underscoring the remarkable benefits experienced from using Aranesp to augment their training and competitive readiness.
While Aranesp offers significant benefits, it is essential to approach its use with caution. Potential side effects include hypertension, thrombosis, and increased risk of stroke, especially when hemoglobin levels exceed recommended ranges. Athletes should undergo regular monitoring and should adhere to dosage recommendations to mitigate these risks. Additionally, Aranesp is contraindicated in individuals with uncontrolled hypertension or known hypersensitivity to any component of the formulation. It is crucial to consult a healthcare professional before incorporating Aranesp into any training regimen, ensuring it aligns with individual health profiles and performance goals. Awareness of the ethical implications and rules regarding performance-enhancing substances in competitive sports should be understood thoroughly.
| Active substance | Erythropoietin |
|---|---|
| Classification | Glycoprotein Cytokine |
| Acne | No |
| Water Retention | No |
| HBR | No |
| Hepatotoxicity | No |
| Aromatization | No |
| Lab Test | Detection via specific blood tests (e.g., EPO doping test, isoelectric focusing) |
| Also known as | EPO |
| WAREHOUSE | International Warehouse 2 |
| Blood pressure | Can cause an increase in blood pressure |
| Trade name | Epogen, Procrit, Eprex, others |
| Storage conditions | Refrigerated, typically between 2-8В°C |
| Chemical name | Erythropoietin |
| Formula | Not applicable as it is a glycoprotein |
| Substance class | Hormone, specifically a growth factor |
| Main action | Stimulates erythropoiesis (production of red blood cells) |
| Half-life | Varies, typically 4-13 hours depending on the type (recombinant forms) |
| Dosage (medical) | Typically 50-300 units/kg three times a week, dose adjusted based on hemoglobin levels and patient response |
| Dosage (sports) | Misuse can involve 20-50 IU/kg of body weight, three times per week |
| Effects | Increases red blood cell count, enhances oxygen transport and aerobic capacity |
| Side effects | Hypertension, thrombosis, increased risk of stroke, headache, flu-like symptoms |
| Use in sports | Banned – used to increase endurance and performance |
| Manufacturer | Amgen |
€156.00
Reviews
There are no reviews yet.